LAS VEGAS -- CMS announced that about 25% of Medicare.gov accounts have used a digital identity verification platform, where a beneficiary takes a selfie and a photo of their physical ID to verify they are who they say they are, since the agency quietly added the feature to the government website earlier this month.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
Home
Top Story
MAHA Conference Revives Vaccine-Autism Claims Despite GOP Push To Reframe Health Agenda
As the White House and Republican allies try to shift the national health debate away from anti-vaccine rhetoric and toward issues such as food safety and drug pricing, prominent vaccine skeptics aligned with the “Make America Healthy Again” movement continue to promote claims linking vaccines to autism and chronic illness.
Drug Pricing Deals In Spotlight
Senate Dems Ask How Trump’s MFN Deals Mesh With GENEROUS Model
Key Senate Democrats are demanding top drug makers explain how the secretive most-favored nation deals they reached with President Donald Trump last December mesh with CMS’ efforts to also apply MFN pricing to state Medicaid programs under its latest voluntary model, saying state officials are crunched by the reconciliation law’s deep Medicaid cuts and need transparency on future drug pricing.
Democrats Ask Trump For Copies Of MFN Deals
Democrats Seek Details On GLOBE, GUARD, GENEROUS Models, Warn Of Pharma Deal Loopholes
Latest News
An artificial intelligence advisor to the FDA commissioner touted the agency’s efforts to individually assess AI health technologies based on their specific functions, leading to individualized risk-based regulations.
Consumer group Public Citizen says it will encourage compulsory licensing of generic drugs if Pfizer follows through on a threat it made in January to withhold its drugs from France unless the European country pays more for the company’s medicines.
FDA issued a final rule giving drug makers seven years to adopt a uniform 12-digit format for the national drug code (NDC), an adjustment that will ensure the United States does not run out of unique 10-digit codes that are used to uniquely identify drugs marketed in the United States.
Beneficiary advocates are urging national, state and local organizations to sign a letter urging Congress to protect home and community-based services (HCBS) as the Trump administration and GOP lawmakers continue to target fraud in CMS, particularly in Democrat-led states.